Lower Age Limit Addresses Increasing Calls from Clinicians Seeking Access to the PrecivityAD2™ Test for Patients With Earlier ...

Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their OptionsIf ...

With 45-plus locations and more than 225 providers, the physician-owned practice makes it simpler for families to get all the appointments they need, while ensuring comprehensive, complete care.

The "United States Narcolepsy Drugs Market to Reach US$ 2,233.56 Million by 2033 - 7.88% CAGR Driven by Novel Therapies and Better Diagnosis" report has been added to ResearchAndMarkets.com's offering ...

The "Europe Neonatal Intensive Care Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.The Europe Neonatal ...

Advent International (“Advent”), a leading global private equity investor, today announced that it has signed a definitive agreement to acquire PatientPoint, Inc. (“PatientPoint” or the “Company”), ...

Presentations highlighting CRISPR genetic and epigenetic editing therapies, machine learning, and corporate updates at multiple industry-leading events in Fall 2025ALAMEDA, Calif.--(BUSINESS ...

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointment ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced that management will ...

Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced participation in ...

Phase 2 study showed a doubling of the survival rate of metastatic pancreatic cancer patients at Year 1, an unprecedented ...

(OLE) studies demonstrate the potential for disease modification with durable seizure reductions and improvements in cognition and behavior on top of standard anti-seizure medicines –– Substantial ...